{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:38:36Z","timestamp":1762504716087,"version":"3.41.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2001,9]]},"DOI":"10.1023\/a:1012965617685","type":"journal-article","created":{"date-parts":[[2002,12,23]],"date-time":"2002-12-23T15:14:19Z","timestamp":1040656459000},"page":"167-177","source":"Crossref","is-referenced-by-count":29,"title":["Endocrine inactive and gonadotroph adenomas: diagnosis and management"],"prefix":"10.1007","volume":"54","author":[{"given":"Marco","family":"Losa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Mortini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Barzaghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Franzin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Giovanelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"358621_CR1","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1210\/edrv-6-4-552","volume":"6","author":"PJ Snyder","year":"1993","unstructured":"Snyder PJ: Gonadotroph cell adenomas of the pituitary. Endocrinol Rev 6: 552\u2013563, 1993","journal-title":"Endocrinol Rev"},{"key":"358621_CR2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3171\/jns.1987.66.2.0244","volume":"66","author":"PM Black","year":"1987","unstructured":"Black PM, Hsu DW, Klibanski A, Kliman B, Jameson JL, Ridgway EC, Hedley-White ET, Zervas NT: Hormone production in clinically nonfunctioning pituitary adenomas. J Neurosurg 66: 244\u2013250, 1987","journal-title":"J Neurosurg"},{"key":"358621_CR3","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1365-2265.1990.tb00914.x","volume":"32","author":"MC White","year":"1990","unstructured":"White MC, Daniels M, Newland P, Thompson CJ, Cook D, Dewar J, Perry R, Jewitt R, Mathias D, Murdoch AP, Kendall-Taylor P: LH and FSH secretion and responses to GnRH and TRH in patients with clinically functionless pituitary adenomas. Clin Endocrinol (Oxf) 32: 681\u2013688, 1990","journal-title":"Clin Endocrinol (Oxf)"},{"key":"358621_CR4","first-page":"159","volume-title":"Pituitary Adenomas: New Trends in Basic and Clinical Research","author":"B Ambrosi","year":"1991","unstructured":"Ambrosi B, Faglia G, and the Multicenter Pituitary Tumor Study Group, Lombardia Region: Epidemiology of pituitary tumors. In: Faglia G, Beck-Peccoz P, Ambrosi B, Travaglini P, Spada A (eds) Pituitary Adenomas: New Trends in Basic and Clinical Research. Excerpta Medica, Amsterdam, 1991, pp 159\u2013168"},{"key":"358621_CR5","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1210\/jcem-62-6-1173","volume":"62","author":"BM Arafah","year":"1986","unstructured":"Arafah BM: Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 62: 1173\u20131179, 1986","journal-title":"J Clin Endocrinol Metab"},{"key":"358621_CR6","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1097-0142(19910815)68:4<860::AID-CNCR2820680431>3.0.CO;2-4","volume":"68","author":"R Comtois","year":"1991","unstructured":"Comtois R, Beauregard H, Somma M, Serri O, Aris-Jilwan N, Hardy J: The clinical and endocrine outcome to trans-sphenoidal microsurgery of nonsecreting pituitary adenomas. Cancer 68: 860\u2013866, 1991","journal-title":"Cancer"},{"key":"358621_CR7","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0889-8529(18)30474-2","volume":"16","author":"A Klibanski","year":"1987","unstructured":"Klibanski A: Nonsecreting pituitary tumors. Endocrinol Metab Clin North Am 16: 793\u2013804, 1987","journal-title":"Endocrinol Metab Clin North Am"},{"key":"358621_CR8","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1210\/jcem-59-6-1220","volume":"59","author":"M Berezin","year":"1984","unstructured":"Berezin M, Olchovsky D, Pines A, Tadmor R, Lunenfeld B: Reduction of follicle-stimulating hormone (FSH) secretion in FSH-producing pituitary adenoma by bromocriptine. J Clin Endocrinol Metab 59: 1220\u20131223, 1984","journal-title":"J Clin Endocrinol Metab"},{"key":"358621_CR9","first-page":"591","volume":"80","author":"A Djerassi","year":"1995","unstructured":"Djerassi A, Coutifaris C, West VA, Asa SL, Kapoor SC, Pavlou SN, Snyder PJ: Gonadotroph adenoma in a premenopausal woman secreting follicle-stimulating hormone and causing ovarian hyperstimulation. J Clin Endocrinol Metab 80: 591\u2013594, 1995","journal-title":"J Clin Endocrinol Metab"},{"key":"358621_CR10","first-page":"3450","volume":"83","author":"S Christin-Maitre","year":"1998","unstructured":"Christin-Maitre S, Rongieres-Bertrand C, Kottler M, Lahlou N, Frydman R, Touraine P, Bouchard P: A spontaneous and severe hyperstimulation of the ovaries revealing a gonadotroph adenoma. J Clin Endocrinol Metab 83: 3450\u20133453, 1998","journal-title":"J Clin Endocrinol Metab"},{"key":"358621_CR11","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1210\/jcem.84.11.6138","volume":"84","author":"MJ Valimaki","year":"1999","unstructured":"Valimaki MJ, Tiitinen A, Alfthan H, Paetau A, Poranen A, Sane T, Stenman UH: Ovarian hyperstimulation caused by a gonadotroph adenoma secreting follicle-stimulating hormone in 28-year-old woman. J Clin Endocrinol Metab 84: 4204\u20134208, 1999","journal-title":"J Clin Endocrinol Metab"},{"key":"358621_CR12","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1210\/jcem-42-3-544","volume":"42","author":"PJ Snyder","year":"1976","unstructured":"Snyder PJ, Sterling FH: Hypersecretion of LH and FSH by a pituitary adenoma. J Clin Endocrinol Metab 42: 544\u2013550, 1976","journal-title":"J Clin Endocrinol Metab"},{"key":"358621_CR13","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2265.1989.tb01265.x","volume":"31","author":"D Heseltine","year":"1998","unstructured":"Heseltine D, White MC, Kendall-Taylor P, De Kretser DM, Kelly W: Testicular enlargement and elevated serum inhibin concentrations occur in patients with pituitary macroadenomas secreting FSH. Clin Endocrinol (Oxf) 31: 411\u2013423, 1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"358621_CR14","first-page":"167","volume":"102","author":"M Faggiano","year":"1983","unstructured":"Faggiano M, Criscuolo T, Perrone I, Quarto C, Sinisi AA: Sexual precocity in a boy due to hypersecretion of LH and 175 prolactin by a pituitary adenoma. Acta Endocrinol (Copenh) 102: 167\u2013172, 1983","journal-title":"Acta Endocrinol (Copenh)"},{"key":"358621_CR15","first-page":"569","volume":"122","author":"B Ambrosi","year":"1990","unstructured":"Ambrosi B, Bassetti M, Ferrario R, Medri G, Giannattasio G, Faglia G: Precocious puberty in a boy with a PRL-LH and FSH secreting pituitary tumor: hormonal and immunocytochemical studies. Acta Endocrinol (Copenh) 122: 569\u2013576, 1990","journal-title":"Acta Endocrinol (Copenh)"},{"key":"358621_CR16","first-page":"1103","volume":"78","author":"K Saccomanno","year":"1994","unstructured":"Saccomanno K, Spada A, Bassetti M, Gil-del-Alamo P, Faglia G: Immunodetection of chorionic gonadotropin and its subunits in human nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 78: 1103\u20131107, 1994","journal-title":"J Clin Endocrinol Metab"},{"key":"358621_CR17","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1210\/jcem-70-4-859","volume":"70","author":"DS Oppenheim","year":"1990","unstructured":"Oppenheim DS, Kana AR, Sangha JS, Klibanski A: Prevalence of alpha-subunit hypersecretion in patients with pituitary tumors: clinically non-functioning and somatotroph adenomas. J Clin Endocrinol Metab 70: 859\u2013864, 1990","journal-title":"J Clin Endocrinol Metab"},{"key":"358621_CR18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1530\/eje.0.1330033","volume":"133","author":"P Gil-del-Alamo","year":"1995","unstructured":"Gil-del-Alamo P, Saccomanno K, Lania A, Pettersson KSI, Beck-Peccoz P, Spada A: Serum levels of \u03b2-subunit of chorionic gonadotropin in patients with pituitary tumors. Eur J Endocrinol 133: 33\u201337, 1995","journal-title":"Eur J Endocrinol"},{"key":"358621_CR19","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1210\/jcem-68-6-1128","volume":"68","author":"DJ Kwekkeboom","year":"1989","unstructured":"Kwekkeboom DJ, de Jong FH, Lamberts SWJ: Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone and bromocriptine. J Clin Endocrinol Metab 68: 1128\u20131135, 1989","journal-title":"J Clin Endocrinol Metab"},{"key":"358621_CR20","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJM199102283240904","volume":"324","author":"L Daneshdoost","year":"1991","unstructured":"Daneshdoost L, Gennarelli TA, Bashey HM, Savino PJ, Sergott RC, Bosley TM, Snyder PJ: Recognition of gonadotroph adenomas in women. N Engl J Med 324: 589\u2013594, 1991","journal-title":"N Engl J Med"},{"key":"358621_CR21","first-page":"1343","volume":"74","author":"L Katznelson","year":"1992","unstructured":"Katznelson L, Alexander JM, Bikkal HA, Jameson JL, Hsu DW, Klibanski A: Imbalanced follicle-stimulating hormone beta-subunit hormone biosynthesis in human pituitary adenomas. J Clin Endocrinol Metab 74: 1343\u20131351, 1992","journal-title":"J Clin Endocrinol Metab"},{"key":"358621_CR22","first-page":"1352","volume":"77","author":"L Daneshdoost","year":"1993","unstructured":"Daneshdoost L, Gennarelli TA, Bashey HM, Savino PJ, Sergott RC, Bosley TM, Snyder PJ: Identification of gonadotroph adenomas in men with clinically nonfunctioning adenomas by the luteinizing hormone \u03b2 subunit response to thyrotropin-releasing hormone. J Clin Endocrinol Metab 77: 1352\u20131355, 1993","journal-title":"J Clin Endocrinol Metab"},{"key":"358621_CR23","unstructured":"Losa M, Terreni MR, Mortini P, Acerno S, Giovanelli M: Responsiveness of gonadotropins to TRH in patients with nonfunctioning pituitary adenomas: correlation with immunohistochemical results. Highlights in Molecular and Clinical Endocrinology, Ares-Serono Symposia Series - Frontiers in Endocrinology, Vol. 9, 1994, pp 155\u2013158"},{"key":"358621_CR24","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1210\/jcem-64-3-524","volume":"64","author":"SWJ Lamberts","year":"1987","unstructured":"Lamberts SWJ, Verleun T, Oosterom R, Hofland L, van Ginkel LA, Loeber JG, van Vroonhoven CC, Stefanko SZ, de Jong FH: The effects of bromocriptine, thyrotropin-releasing hormone, and gonadotropin-releasing hormone on hormone secretion by gonadotropin-secreting pituitary adenomas in vivo and in vitro. J Clin Endocrinol Metab 64: 524\u2013530, 1987","journal-title":"J Clin Endocrinol Metab"},{"key":"358621_CR25","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1210\/jcem-73-6-1281","volume":"73","author":"MH Samuels","year":"1991","unstructured":"Samuels MH, Henry P, Kleinschmidts-Demasters BK, Lillehei K, Ridgway EC: Pulsatile glycoprotein hormone secretion in glycoprotein-producing pituitary tumors. J Clin Endocrinol Metab 73: 1281\u20131288, 1991","journal-title":"J Clin Endocrinol Metab"},{"key":"358621_CR26","first-page":"1363","volume":"76","author":"GA McGrath","year":"1993","unstructured":"McGrath GA, Goncalves RJ, Udupa JK, Grossman RI, Pavlou SN, Molitch ME, Rivier J, Vale WW, Snyder PJ: New technique for quantitation of pituitary adenoma size: use in evaluating treatment of gonadotroph adenomas with a gonadotropin-releasing hormone antagonist. J Clin Endocrinol Metab 76: 1363\u20131368, 1993","journal-title":"J Clin Endocrinol Metab"},{"key":"358621_CR27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/jcem-68-1-81","volume":"68","author":"A Klibanski","year":"1989","unstructured":"Klibanski A, Jameson JL, Biller BM, Crowley WF Jr, Zervas NT, Rivier J, Vale WW, Bikkal H: Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors. J Clin Endocrinol Metab 68: 81\u201386, 1989","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl1","key":"358621_CR28","first-page":"6","volume":"129","author":"SWJ Lamberts","year":"1993","unstructured":"Lamberts SWJ, de Herder WW, Kwekkeboom DJ, van der Lely AJ, Nobels FRE, Krenning EP: Current tools in the diagnosis of pituitary tumors. Acta Endocrinol (Copenh) 129(Suppl 1): 6\u201312, 1993","journal-title":"Acta Endocrinol (Copenh)"},{"key":"358621_CR29","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0950-351X(95)80402-1","volume":"9","author":"WW De Herder","year":"1995","unstructured":"De Herder WW, Lamberts SWJ: 1995 Imaging of pituitary tumours. Bailliere's Clin Endocrinol Metab 9: 367\u2013389, 1995","journal-title":"Bailliere's Clin Endocrinol Metab"},{"key":"358621_CR30","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/BF00181765","volume":"20","author":"EP Krenning","year":"1993","unstructured":"Krenning EP, Kwekkeboom DJ, Bakker WH, Breeman WAP, Kooij PPM, Oei HJ, van Hagen M, Postema PTE, de Jong M, Reubi JC, Visser TJ, Reijs AEM, Hofland LJ, Koper JW, Lamberts SWJ: Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]-and [123I-Tyr3]-octreotide: the Rotterdam experience in more than 1000 patients. Eur J Nucl Med 20: 716\u2013731, 1993","journal-title":"Eur J Nucl Med"},{"key":"358621_CR31","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1210\/jcem-73-4-850","volume":"73","author":"G Faglia","year":"1991","unstructured":"Faglia G, Bazzoni N, Spada A, Arosio M, Ambrosi B, Spinelli F, Sara R, Bonino C, Lunghi F: In vivo detection of somatostatin receptors in patients with functionless pituitary adenomas by means of a radioiodinated analog of somatostatin ([123I]SDZ 204-090). J Clin Endocrinol Metab 73: 850\u2013856, 1991","journal-title":"J Clin Endocrinol Metab"},{"key":"358621_CR32","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1210\/edrv-12-4-450","volume":"12","author":"SW Lamberts","year":"1991","unstructured":"Lamberts SW, Krenning EP, Reubi JC: The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocrinol Rev 12: 450\u2013482, 1991","journal-title":"Endocrinol Rev"},{"key":"358621_CR33","first-page":"855","volume":"30","author":"M Bergstr\u00f6m","year":"1992","unstructured":"Bergstr\u00f6m M, Muhr C, Jossan S, Lilja A, Nyberg G, L\u00e5ngstr\u00f6m B: Differentiation of pituitary adenoma and meningioma: visualization with positron emission tomography and [11C]-L-deprenyl. Neurosurgery 30: 855\u2013861, 1992","journal-title":"Neurosurgery"},{"key":"358621_CR34","first-page":"595","volume":"114","author":"M Koga","year":"1987","unstructured":"Koga M, Nakao H, Arao M, Sato B, Noma K, Morimoto Y, Kishimoto S, Mori S, Uozumi T: Demonstration of specific dopamine receptors on human pituitary adenomas. Acta Endocrinol (Copenh) 114: 595\u2013602, 1987","journal-title":"Acta Endocrinol (Copenh)"},{"key":"358621_CR35","first-page":"1149","volume":"24","author":"G Lucignani","year":"1997","unstructured":"Lucignani G, Losa M, Moresco RM, Del Sole A, Matarrese M, Bettinardi V, Mortini P, Giovanelli M, Fazio F: Differentiation of clinically non-functioning pituitary adenomas from meningiomas and craniopharyngiomas by positron emission tomography with [18F]fluoro-ethylspiperone. Eur J Nucl Med 24: 1149\u20131155, 1997","journal-title":"Eur J Nucl Med"},{"key":"358621_CR36","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1600-0404.1982.tb04533.x","volume":"66","author":"J Salmi","year":"1982","unstructured":"Salmi J, Grahne B, Valtonen S, Pelkonen R: Recurrence of chromophobe pituitary adenomas after operation and postoperative radiotherapy. Acta Neurol Scand 66: 681\u2013689, 1982","journal-title":"Acta Neurol Scand"},{"key":"358621_CR37","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3171\/jns.1986.64.5.0713","volume":"64","author":"MJ Ebersold","year":"1986","unstructured":"Ebersold MJ, Quast LM, Laws ER Jr, Scheithauer B, Randall RV: Long-term results in transsphenoidal removal of nonfunctioning pituitary adenomas. J Neurosurg 64: 713\u2013719, 1986","journal-title":"J Neurosurg"},{"key":"358621_CR38","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1365-2265.1987.tb00809.x","volume":"26","author":"JS Bevan","year":"1987","unstructured":"Bevan JS Adams CB, Burke CW, Morton KE, Molyneux AJ, Moore RA, Esiri MM: Factors in the outcome of transsphenoidal surgery for prolactinoma and nonfunctioning pituitary tumour, including pre-operative bromocriptine therapy. Clin Endocrinol (Oxf) 26: 541\u2013556, 1987","journal-title":"Clin Endocrinol (Oxf)"},{"key":"358621_CR39","first-page":"417","volume":"265","author":"PE Harris","year":"1989","unstructured":"Harris PE, Afshar F, Coates P, Doniach I, Wass JAH, Besser GM, Grossman A: The effects of transsphenoidal surgery on endocrine function and visual fields in patients with functionless pituitary tumours. Q J Med 265: 417\u2013427, 1989","journal-title":"Q J Med"},{"key":"358621_CR40","first-page":"313","volume-title":"Pituitary adenomas: New Trends in Basic and Clinical Research","author":"M Giovanelli","year":"1991","unstructured":"Giovanelli M, Losa M, Baiguini M, Motti E, Ducati A: Transcranial vs. transsphenoidal approach in the surgical treatment of pituitary adenomas. In: Faglia G, Beck-Peccoz P, Ambrosi B, Travaglini P, Spada A (eds) Pituitary adenomas: New Trends in Basic and Clinical Research. Excerpta Medica, Amsterdam, 1991, pp 313\u2013320"},{"key":"358621_CR41","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/014107689108400308","volume":"84","author":"GR Shone","year":"1991","unstructured":"Shone GR, Richards SH, Hourihan MD, Hall R, Thomas JP, Scanlon MF: Non-secretory adenomas of the pituitary treated by trans-ethmoidal sellotomy. J R Soc Med 84: 140\u2013143, 1991","journal-title":"J R Soc Med"},{"issue":"Suppl1","key":"358621_CR42","first-page":"21","volume":"129","author":"G Sassolas","year":"1993","unstructured":"Sassolas G, Trouillas J, Treluyer C, Perrin G: Management of nonfunctioning pituitary adenomas. Acta Endocrinol (Copenh) 129 (Suppl 1): 21\u201326, 1993","journal-title":"Acta Endocrinol (Copenh)"},{"key":"358621_CR43","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/BF03347763","volume":"17","author":"M Marazuela","year":"1994","unstructured":"Marazuela M, Astigarraga B, Vicente A, Estrada J, Cuerda C, Garcia-Uria J, Lucas T: Recovery of visual and endocrine function following transsphenoidal surgery of large nonfunctioning pituitary adenomas. J Endocrinol Invest 17: 703\u2013707, 1994","journal-title":"J Endocrinol Invest"},{"key":"358621_CR44","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/archotol.1995.01890030051008","volume":"121","author":"B Petruson","year":"1995","unstructured":"Petruson B, Jakobsson KE, Elfverson J, Bengtsson BA: Five-year follow-up of nonsecreting pituitary adenomas. Arch Otolaryngol Head Neck Surg 121: 317\u2013322, 1995","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"358621_CR45","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/BF03350330","volume":"21","author":"A Colao","year":"1998","unstructured":"Colao A, Cerbone G, Cappabianca P, Ferone D, Alfieri A, Di Salle F, Faggiano A, Merola B, de Divitiis E, Lombardi G: Effect of surgery and radiotherapy on visual and endocrine function in nonfunctioning pituitary adenomas. J Endocrinol Invest 21: 284\u2013290, 1998","journal-title":"J Endocrinol Invest"},{"key":"358621_CR46","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1210\/jcem.84.10.6019","volume":"84","author":"SM Webb","year":"1999","unstructured":"Webb SM, Rigla M, W\u00e4gner A, Oliver B, Bartumeus F: Recovery of hypopituitarism after neurosurgical treatment of pituitary adenomas. J Clin Endocrinol Metab 84: 3696\u20133700, 1999","journal-title":"J Clin Endocrinol Metab"},{"key":"358621_CR47","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1365-2265.2000.01153.x","volume":"53","author":"AC Woollons","year":"2000","unstructured":"Woollons AC, Hunn MK, Rajapakse YR, Toomath R, Hamilton DA, Conaglen JV, Balakrishnan V: Nonfunctioning pituitary adenomas: indications for postoperative radiotherapy. Clin Endocrinol (Oxf) 53: 713\u2013717, 2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"358621_CR48","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/00006123-200012000-00009","volume":"47","author":"M Losa","year":"2000","unstructured":"Losa M, Franzin A, Mangili F, Terreni MR, Barzaghi R, Veglia F, Mortini P, Giovanelli M: Proliferation index of nonfunctioning pituitary adenomas: correlations with clinical characteristics and long term follow up results. Neurosurgery 47: 1313\u20131319, 2000","journal-title":"Neurosurgery"},{"key":"358621_CR49","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/00006123-199809000-00020","volume":"43","author":"KO Lillehei","year":"1998","unstructured":"Lillehei KO, Kirschman DL, Kleinschmidt-DeMasters BK, Ridgway EC: Reassessment of the role of radiation therapy in the treatment of endocrine-inactive pituitary macroadenomas. Neurosurgery 43: 432\u2013439, 1998","journal-title":"Neurosurgery"},{"key":"358621_CR50","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0090-3019(99)00157-3","volume":"52","author":"V Rajaraman","year":"1999","unstructured":"Rajaraman V, Schulder M: Postoperative MRI appearance after transsphenoidal pituitary tumor resection. Surg Neurol 52: 592\u2013599, 1999","journal-title":"Surg Neurol"},{"key":"358621_CR51","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1148\/98.1.149","volume":"98","author":"TP Hayes","year":"1971","unstructured":"Hayes TP, Davis RA, Raventos A: The treatment of pituitary chromophobe adenomas. Radiology 98:149\u2013153, 1971","journal-title":"Radiology"},{"key":"358621_CR52","first-page":"1","volume-title":"Radiation Oncology Annual","author":"GE Sheline","year":"1983","unstructured":"Sheline GE, Tyrrell B: Pituitary adenomas. In: Phillips TL, Pinstenma DA (eds) Radiation Oncology Annual. Raven Press, New York, 1983, pp 1\u201335"},{"key":"358621_CR53","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2265.1998.00393.x","volume":"48","author":"NJL Gittoes","year":"1998","unstructured":"Gittoes NJL, Bates AS, Tse W, Bullivan B, Sheppard MC, Clayton RN, Stewart PM: Radiotherapy for non-functioning pituitary tumours. Clin Endocrinol (Oxf) 48: 331\u2013337, 1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"358621_CR54","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1365-2265.1999.00865.x","volume":"51","author":"HE Turner","year":"1999","unstructured":"Turner HE, Stratton IM, Byrne JV, Adams CBT, Wass JAH: Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation - a follow-up study. Clin Endocrinol (Oxf) 51: 281\u2013284, 1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"358621_CR55","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/BF00311392","volume":"84","author":"M Shibuya","year":"1992","unstructured":"Shibuya M, Saito F, Miwa T, Davis RL, Wilson CB, Hoshino T: Histochemical study of pituitary adenomas with Ki-67 and anti-DNA polymerase \u03b2 monoclonal antibodies, bromodeoxyuridine labeling, and nucleolar organizer region counts. Acta Neuropathol 84: 178\u2013183, 1992","journal-title":"Acta Neuropathol"},{"key":"358621_CR56","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3171\/jns.1993.78.5.0753","volume":"78","author":"DW Hsu","year":"1993","unstructured":"Hsu DW, Hakim F, Biller BMK, de la Monte S, Zervas NT, Klibanski A, Hedley-White ET: Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. J Neurosurg 78: 753\u2013761, 1993","journal-title":"J Neurosurg"},{"key":"358621_CR57","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/BF01411125","volume":"138","author":"SM Ekramullah","year":"1996","unstructured":"Ekramullah SM, Saitoh Y, Arita N, Ohnishi T, Hayakawa T: The correlation of Ki-67 staining indices with tumour doubling times in regrowing non-functioning pituitary adenomas. Acta Neurochir (Wien) 138: 1449\u20131455, 1996","journal-title":"Acta Neurochir (Wien)"},{"key":"358621_CR58","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0090-3019(97)00102-X","volume":"48","author":"K Yonezawa","year":"1997","unstructured":"Yonezawa K, Tamaki N, Kokunai T: Clinical features and growth fractions of pituitary adenomas. Surg Neurol 48: 494\u2013500, 1997","journal-title":"Surg Neurol"},{"key":"358621_CR59","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3171\/jns.1990.72.4.0594","volume":"72","author":"SC Rush","year":"1990","unstructured":"Rush SC, Kupersmith MJ, Leuch I, Cooper P, Ransohoff J, Newall J: Neuro-ophthalmological assessment of vision before and after radiation therapy alone for pituitary macroadenomas. J Neurosurg 72: 594\u2013599, 1990","journal-title":"J Neurosurg"},{"key":"358621_CR60","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF02327388","volume":"6","author":"PW Grigsby","year":"1988","unstructured":"Grigsby PW, Simpson JR, Stokes S, Marks JE, Fineberg B: Results of surgery and irradiation or irradiation alone for pituitary adenomas. J Neuro-Oncol 6: 129\u2013134, 1988","journal-title":"J Neuro-Oncol"},{"key":"358621_CR61","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0360-3016(89)90384-2","volume":"17","author":"SC Rush","year":"1989","unstructured":"Rush SC, Newall J: Pituitary adenoma: the efficacy of radiotherapy as the sole treatment. Int J Radiat Oncol Biol Phys 17: 165\u2013169, 1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"358621_CR62","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0360-3016(91)90677-V","volume":"21","author":"WM McCollough","year":"1991","unstructured":"McCollough WM, Marcus RB Jr, Rhoton AL Jr, Ballinger WE, Million RR: Long-term follow-up of radiotherapy for pituitary adenoma: the absence of late recurrence after greater than or equal to 4500cGy. Int J Radiat Oncol Biol Phys 21: 607\u2013614, 1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"358621_CR63","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2265.1993.tb02137.x","volume":"38","author":"M Brada","year":"1993","unstructured":"Brada M, Rajan B, Traish D, Ashley S, Holmes-Sellors PJ, Nussey S, Uttley D: The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol (Oxf) 38: 571\u2013578, 1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"358621_CR64","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3171\/jns.1998.89.6.0933","volume":"89","author":"P Breen","year":"1998","unstructured":"Breen P, Flickinger JC, Kondziolka D, Martinez AJ: Radiotherapy for nonfunctional pituitary adenoma: analysis of long-term tumor control. J Neurosurg 89: 933\u2013938, 1998","journal-title":"J Neurosurg"},{"key":"358621_CR65","first-page":"2409","volume":"63","author":"JC Flickinger","year":"1989","unstructured":"Flickinger JC, Nelson PB, Martinez AJ, Deutsch M, Taylor F: Radiotherapy of nonfunctional adenomas of the pituitary gland. Results with long-term follow-up. Cancer 63: 2409\u20132414, 1989","journal-title":"Results with long-term follow-up. Cancer"},{"key":"358621_CR66","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1365-2265.1999.00854.x","volume":"51","author":"PN Plowman","year":"1999","unstructured":"Plowman PN: Pituitary adenoma radiotherapy - when, who and how? Clin Endocrinol (Oxf) 51: 265\u2013271, 1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"358621_CR67","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0360-3016(92)90941-A","volume":"30","author":"RW Tsang","year":"1994","unstructured":"Tsang RW, Brierley JD, Panzarella T, Gospodarowicz MK, Sutcliffe SB, Simpson WJ: Radiation therapy for pituitary adenoma: treatment outcome and prognostic factors. Int J Radiat Oncol Biol Phys 30: 557\u2013565, 1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"358621_CR68","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2265.1986.tb03610.x","volume":"25","author":"JS Bevan","year":"1986","unstructured":"Bevan JS, Burke CW: Non-functioning pituitary adenomas do not regress during bromocriptine therapy but possess membrane-bound dopamine receptors which bind bromocriptine. Clin Endocrinol (Oxf) 25: 561\u2013572, 1986","journal-title":"Clin Endocrinol (Oxf)"},{"key":"358621_CR69","first-page":"281","volume":"96","author":"F Wollesen","year":"1982","unstructured":"Wollesen F, Andersen T, Karle A: Size reduction of extrasellar pituitary tumours during bromocriptine treatment. Quantitation of effect on different types of tumours. Ann Intern Med 96: 281\u2013286, 1982","journal-title":"Quantitation of effect on different types of tumours. Ann Intern Med"},{"key":"358621_CR70","first-page":"383","volume-title":"Pituitary adenomas: New Trends in Basic and Clinical Research","author":"A Liuzzi","year":"1991","unstructured":"Liuzzi A, Dallabonzana D, Oppizzi G, Arrigoni L, Cozzi R, Strada S, Benini Z, Chiodini J, Chiodini PG: Is there a real medical treatment for \u2018non secreting\u2019 pituitary adenomas? In: Faglia G, Beck-Peccoz P, Ambrosi B, Travaglini P, Spada A (eds) Pituitary adenomas: New Trends in Basic and Clinical Research. Excerpta Medica, Amsterdam, 1991, pp 383\u2013390"},{"key":"358621_CR71","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1210\/edrv-13-2-220","volume":"13","author":"JS Bevan","year":"1992","unstructured":"Bevan JS, Webster J, Burke CW, Scanlon MF: Dopamine agonists and pituitary tumour shrinkage. Endocrinol Rev 13: 220\u2013240, 1992","journal-title":"Endocrinol Rev"},{"key":"358621_CR72","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1365-2265.1986.tb03625.x","volume":"25","author":"MC D'Emden","year":"1986","unstructured":"D'Emden MC, Harrison LC: Rapid improvement in visual field defects following bromocriptine treatment of patients with non-functioning pituitary adenomas. Clin Endocrinol (Oxf) 25: 697\u2013702, 1986","journal-title":"Clin Endocrinol (Oxf)"},{"key":"358621_CR73","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000181286","volume":"32","author":"PP Garcia-Luna","year":"1989","unstructured":"Garcia-Luna PP, Leal-Cerro A, Pereira JL, Montero C, Acosta D, Trujillo F, Mazuelos C, Astorga R: Rapid improvement in visual defects with parenteral depot bromocriptine in a patient with a nonfunctioning pituitary adenoma. Horm Res 32: 183\u2013187, 1989","journal-title":"Horm Res"},{"key":"358621_CR74","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2265.1992.tb00953.x","volume":"36","author":"DJ Kwekkeboom","year":"1992","unstructured":"Kwekkeboom DJ, Lamberts SWJ: Long-term treatment with dopamine agonist CV 205-502 of patients with a clinically non-functioning, gonadotroph, or \u03b2-subunit secreting pituitary adenoma: Clin Endocrinol (Oxf) 36: 171\u2013176, 1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"358621_CR75","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1210\/jcem.83.1.4493","volume":"83","author":"D Ferone","year":"1998","unstructured":"Ferone D, Lastoria S, Colao A, Varrella P, Cerbone G, Acampa W, Merola B, Salvatore M, Lombardi G: Correlation of scintigraphic results using 123I-methoxybenzamide with hormone levels and tumour size response to quinagolide in patients with pituitary adenomas. J Clin Endocrinol Metab 83: 248\u2013252, 1998","journal-title":"J Clin Endocrinol Metab"},{"key":"358621_CR76","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1046\/j.1365-2265.2000.00951.x","volume":"52","author":"A Colao","year":"2000","unstructured":"Colao A, Ferone D, Lastoria S, Cerbone G, Di Sarno A, Di Somma C, Lucci R, Lombardi G: Hormone levels and tumour size response to quinagolide and cabergoline in patients with prolactin-secreting and clinically nonfunctioning pituitary adenomas: predictive value of pituitary scintigraphy with 123I-methoxybenzamide. Clin Endocrinol (Oxf) 52: 437\u2013445, 2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"358621_CR77","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1210\/jcem-65-1-65","volume":"65","author":"JC Reubi","year":"1987","unstructured":"Reubi JC, Heitz PU, Landolt AM: Visualization of somatostatin receptors and correlation with immunoreactive growth hormone and prolactin in human pituitary adenomas: evidence for different tumors subclasses. J Clin Endocrinol Metab 65: 65\u201373, 1987","journal-title":"J Clin Endocrinol Metab"},{"key":"358621_CR78","first-page":"1310","volume":"75","author":"TW de Bruin","year":"1992","unstructured":"de Bruin TW, Kwekkeboom DJ, Van'tVerlaat JW, Reubi JC, Krenning EP, Lamberts SW, Croughs RJM: Clinically nonfunctioning pituitary adenoma and octreotide response to long term high dose treatment, and studies in vitro. J Clin Endocrinol Metab 75: 1310\u20131317, 1992","journal-title":"J Clin Endocrinol Metab"},{"key":"358621_CR79","first-page":"786","volume":"41","author":"A Warnet","year":"1997","unstructured":"Warnet A, Harris AG, Renard E, Martin D, James-Deidier A, Chaumet-Riffaud P: A prospective multicenter trial of octreotide in 24 patients with visual defects caused by nonfunctioning and gonadotropin-secreting pituitary adenomas. French Multicenter Octreotide Study Group. Neurosurgery 41: 786\u2013797, 1997","journal-title":"French Multicenter Octreotide Study Group. Neurosurgery"},{"key":"358621_CR80","first-page":"1416","volume":"79","author":"U Pl\u00f6ckinger","year":"1994","unstructured":"Pl\u00f6ckinger U, Reichel M, Fett U, Saeger W, Quabbe HJ: Preoperative octreotide treatment of growth hormonesecreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy. J Clin Endocrinol Metab 79: 1416\u20131423, 1994","journal-title":"J Clin Endocrinol Metab"},{"key":"358621_CR81","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1365-2265.2001.01172.x","volume":"54","author":"M Andersen","year":"2001","unstructured":"Andersen M, Bjerre P, Schr\u00f8der HD, Edal A, H\u00f8llund-Carlsen PF, Pedersen PH, Hagen C: In vivo secretory potential and the effect of combination therapy with octreotide and cabergoline in patients with clinically nonfunctioning pituitary adenomas. Clin Endocrinol (Oxf) 54: 23\u201330, 2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"358621_CR82","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3171\/jns.1989.71.5.0687","volume":"71","author":"A Warnet","year":"1989","unstructured":"Warnet A, Timsit J, Chanson P, Guillausseau P, Zamfirescu F, Harris AG, Derome P, Cophignon J, Lubetzki J: The effect of somatostatin analogue on chiasmal dysfunction from pituitary macroadenomas. J Neurosurg 71: 687\u2013690, 1989","journal-title":"J Neurosurg"},{"key":"358621_CR83","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1210\/jcem-67-1-180","volume":"67","author":"G Sassolas","year":"1988","unstructured":"Sassolas G, Lejeune H, Trouillas J, Forest MG, Claustrat B, Lahlou N, Loras B: Gonadotropin releasing hormone agonists are unsuccessful in reducing tumoral gonadotropin secretion in two patients with gonadotropin secreting pituitary adenomas. J Clin Endocrinol Metab 67: 180\u2013185, 1988","journal-title":"J Clin Endocrinol Metab"},{"key":"358621_CR84","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1530\/eje.0.1300339","volume":"130","author":"P Colombo","year":"1994","unstructured":"Colombo P, Ambrosi A, Saccomanno K, Bassetti M, Cortelazzi D, Faglia G: Effects of long term treatment with the gonadotropin releasing hormone analog nafarelin in patients with non-functioning pituitary adenomas. Eur J Endocrinol 130: 339\u2013345, 1994","journal-title":"Eur J Endocrinol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1012965617685.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1012965617685\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1012965617685.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T09:16:33Z","timestamp":1749633393000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1012965617685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["358621"],"URL":"https:\/\/doi.org\/10.1023\/a:1012965617685","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"type":"print","value":"0167-594X"},{"type":"electronic","value":"1573-7373"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}